Viewing Study NCT04315233


Ignite Creation Date: 2025-12-25 @ 2:42 AM
Ignite Modification Date: 2025-12-30 @ 6:15 PM
Study NCT ID: NCT04315233
Status: RECRUITING
Last Update Posted: 2025-04-22
First Post: 2020-03-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics
Sponsor: University of Utah
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module